The goal of this study was to design and develop a decoy peptide to inhibit IRF5 and determine its effects on myocardial inflammation and vascular EC function in Tsk/+ mice, a murine model of myocardial inflammation and fibrosis and impaired vasodilatation. This evidence concerns the gene IRF5 and myocarditis.